Medifast (MED) Tops Q1 EPS by 41c; Guides Q2 Lower
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.16 -3.72%
EPS Growth %: -195.2%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -195.2%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q1 EPS of $3.67, $0.41 better than the analyst estimate of $3.26. Revenue for the quarter came in at $349 million versus the consensus estimate of $374.3 million.
GUIDANCE:
Medifast sees Q2 2023 EPS of $1.32-$1.44, versus the consensus of $2.82. Medifast sees Q2 2023 revenue of $250-270 million, versus the consensus of $313.16 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Canaan Inc. (CAN) PT Lowered to $2 at BTIG
- Barnes & Noble Education (BNED) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
